James C. Clemmer - 19 Jul 2025 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Role
President and CEO, Director
Signature
/s/ Lawrence T. Weiss, as Attorney in Fact
Issuer symbol
ANGO
Transactions as of
19 Jul 2025
Net transactions value
-$134,111
Form type
4
Filing time
22 Jul 2025, 18:22:18 UTC
Previous filing
18 Jul 2025
Next filing
09 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Clemmer James C President and CEO, Director 14 PLAZA DRIVE, LATHAM /s/ Lawrence T. Weiss, as Attorney in Fact 22 Jul 2025 0001476700

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGO Common Stock Tax liability $2,989 -344 -0.04% $8.69 887,491 19 Jul 2025 Direct F1
transaction ANGO Common Stock Tax liability $72,188 -8,307 -0.94% $8.69 879,184 19 Jul 2025 Direct F2
transaction ANGO Common Stock Tax liability $25,914 -2,982 -0.34% $8.69 876,202 20 Jul 2025 Direct F3
transaction ANGO Common Stock Tax liability $33,020 -3,673 -0.42% $8.99 872,529 20 Jul 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exempt disposition of 344 shares of common stock of AngioDynamics, Inc. ("AngioDynamics") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2024.
F2 The exempt disposition of 8,307 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023.
F3 The exempt disposition of 2,982 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022.
F4 The exempt disposition of 3,673 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021.